Group One Trading’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-20,100
| Closed | -$175K | – | 5951 |
|
|
2018
Q2 | $175K | Sell |
20,100
-20,900
| -51% | -$188K | ﹤0.01% | 3158 |
|
|
2018
Q1 | $416K | Buy |
+41,000
| New | +$344K | ﹤0.01% | 2202 |
|
|
2016
Q4 | – | Sell |
-400
| Closed | -$2K | – | 5107 |
|
|
2016
Q3 | $2K | Sell |
400
-10,000
| -96% | -$66.1K | ﹤0.01% | 4401 |
|
|
2016
Q2 | $73K | Buy |
+10,400
| New | +$73.3K | ﹤0.01% | 3064 |
|
|
2016
Q1 | – | Sell |
-3,000
| Closed | -$31K | – | 5263 |
|
|
2015
Q4 | $31K | Sell |
3,000
-61,900
| -95% | -$718K | ﹤0.01% | 3701 |
|
|
2015
Q3 | $765K | Buy |
+64,900
| New | +$717K | 0.01% | 1449 |
|
|
2015
Q2 | – | Sell |
-26,800
| Closed | -$166K | – | 5393 |
|
|
2015
Q1 | $166K | Buy |
+26,800
| New | +$166K | ﹤0.01% | 2531 |
|
|
2014
Q3 | – | Sell |
-8,000
| Closed | -$55K | – | 5651 |
|
|
2014
Q2 | $55K | Buy |
8,000
+3,000
| +60% | +$20.1K | ﹤0.01% | 3473 |
|
|
2014
Q1 | $36K | Sell |
5,000
-18,000
| -78% | -$124K | ﹤0.01% | 3884 |
|
|
2013
Q4 | $152K | Buy |
+23,000
| New | +$157K | ﹤0.01% | 2670 |
|
Group One Trading's JNP Position: Q3 2016 in Review
Group One Trading sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2016, closing a stake of 6,597 shares — an estimated $43.6K sold.
Group One Trading first reported a position in JNP in Q1 2014 and held it in 7 quarters. The position peaked at $129K in Q1 2016. 46 funds tracked by Wall St. Rank hold JNP as of Q3 2016.
- Group One Trading reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
- Group One Trading sold 6,597 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2016, an estimated $43.6K.
- Group One Trading first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2014 and held it in 7 quarters.
- Group One Trading's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $129K in Q1 2016.
- 46 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2016.
Based on Group One Trading's 13F filing for Q3 2016, filed 14 Nov 2016.